Bispecific antibody-targeted T-cell therapy for acute myeloid leukemia.

Kubicka, Ewa; Lum, Lawrence G; Huang, Manley; Thakur, Archana

Kubicka, Ewa; Lum, Lawrence G; Huang, Manley; Thakur, Archana.

Afiliação

Kubicka E; Cellular Immunotherapy and Bone Marrow Transplant Program, Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA, United States.
Lum LG; Cellular Immunotherapy and Bone Marrow Transplant Program, Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA, United States.
Huang M; Cellular Immunotherapy and Bone Marrow Transplant Program, Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA, United States.
Thakur A; Cellular Immunotherapy and Bone Marrow Transplant Program, Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA, United States.

Front Immunol ; 13: 899468, 2022.

Article em En | MEDLINE | ID: mdl-36389764

Assuntos

Anticorpos Biespecíficos; Leucemia Mieloide Aguda; Camundongos; Animais; Anticorpos Biespecíficos/uso terapêutico; Leucócitos Mononucleares/metabolismo; Subunidade alfa de Receptor de Interleucina-3; Terapia Baseada em Transplante de Células e Tecidos

Palavras-chave

acute myeloid leukemia; anti-CD123; anti-CD33; bispecific antibodies; targeted T cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Anticorpos Biespecíficos Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google